Literature DB >> 7495747

Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC.

M N Liang1, C Beeson, K Mason, H M McConnell.   

Abstract

The region comprising residues 83-107 of the extracytoplasmic domain of the class II MHC-associated invariant chain protein is essential for its functional interaction with MHC proteins. A nested set of peptides that encompass this region, designated the class II invariant chain-derived peptides (CLIP), bind to many MHC proteins and inhibit the binding of antigenic peptides. The kinetics of the reactions between CLIP and five different murine class II MHC proteins have been determined. Specificity of CLIP binding was confirmed by competition with antigenic peptides. Large differences in the reaction rates were observed. For example, half-times of dissociation ranged from 4.4 min to 17.5 h, a > 200-fold difference. These results demonstrate that CLIP bind to MHC heterodimers at a site that involves the polymorphic residues. These data support the hypothesis that the CLIP binding site is within the peptide binding groove. It is further suggested that these differences in kinetic stabilities of CLIP-MHC protein complexes might affect the diversity of endogenous peptides bound to class II MHC proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495747     DOI: 10.1093/intimm/7.9.1397

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

3.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

5.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

7.  Distinct antigen MHC class II complexes generated by separate processing pathways.

Authors:  R Lindner; E R Unanue
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

8.  Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.

Authors:  B J McFarland; J F Katz; C Beeson; A J Sant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

9.  I-Ag7 is subject to post-translational chaperoning by CLIP.

Authors:  Cornelia H Rinderknecht; Ning Lu; Oliver Crespo; Phi Truong; Tieying Hou; Nan Wang; Narendiran Rajasekaran; Elizabeth D Mellins
Journal:  Int Immunol       Date:  2010-06-13       Impact factor: 4.823

10.  Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.

Authors:  Benjamin M Roy; Dmitriy V Zhukov; Jennifer A Maynard
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.